CorVel (CRVL) Competitors

Laboratory Co. of America (NYSE:LH) and CorVel (NASDAQ:CRVL) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation, community ranking and profitability.

Does the media prefer LH or CRVL?

In the previous week, Laboratory Co. of America had 15 more articles in the media than CorVel. MarketBeat recorded 20 mentions for Laboratory Co. of America and 5 mentions for CorVel. CorVel's average media sentiment score of 1.73 beat Laboratory Co. of America's score of 1.52 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Laboratory Co. of America	17 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
CorVel	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Is LH or CRVL more profitable?

CorVel has a net margin of 10.12% compared to Laboratory Co. of America's net margin of 5.73%. CorVel's return on equity of 32.22% beat Laboratory Co. of America's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Laboratory Co. of America	5.73%	15.29%	7.01%
CorVel	10.12%	32.22%	17.66%

Do analysts recommend LH or CRVL?

Laboratory Co. of America presently has a consensus price target of $270.62, indicating a potential upside of 12.17%. Given Laboratory Co. of America's stronger consensus rating and higher possible upside, equities analysts clearly believe Laboratory Co. of America is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Laboratory Co. of America	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87
CorVel	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more risk and volatility, LH or CRVL?

Laboratory Co. of America has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, CorVel has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in LH or CRVL?

95.9% of Laboratory Co. of America shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 0.8% of Laboratory Co. of America shares are owned by company insiders. Comparatively, 47.6% of CorVel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in LH or CRVL?

Laboratory Co. of America received 432 more outperform votes than CorVel when rated by MarketBeat users. Likewise, 63.89% of users gave Laboratory Co. of America an outperform vote while only 63.84% of users gave CorVel an outperform vote.

Company	Underperform	Outperform
Laboratory Co. of America	Outperform Votes 628 63.89%	Underperform Votes 355 36.11%
CorVel	Outperform Votes 196 63.84%	Underperform Votes 111 36.16%

Which has preferable valuation and earnings, LH or CRVL?

Laboratory Co. of America has higher revenue and earnings than CorVel. Laboratory Co. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Laboratory Co. of America	$13.18B	1.53	$746M	$8.65	27.89
CorVel	$871.31M	6.62	$76.25M	$1.70	66.06

Summary

Laboratory Co. of America beats CorVel on 11 of the 19 factors compared between the two stocks.